RxDoctor Payments Data

Alexandra Rehfuss, MD

Pediatric Urology · Columbus, OHNPI 1790129625

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $745 of the $1,182 with a category attached, or 63.0%. Palette Life Sciences, Inc. accounts for 65.0% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $783 and has fallen 92.6% since, to $58 in 2024.

$1,182in general payments, 2019–2025

Across 11 payments — averaging $107.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Palette Life Sciences, Inc.$768
  • Medical Device Business Services, Inc.$305
  • Alnylam Pharmaceuticals Inc.$43
  • Inari Medical, Inc.$31
  • Endo Pharmaceuticals Inc.$20
  • Coloplast$15
$14,040in research payments, 2019–2025

Across 6 payments — averaging $2340.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Urovant Sciences Inc$8K
  • Sumitomo Pharma America, Inc.$7K

What the payments were for

  • Travel & lodging$74563%
  • Food & beverage$13211%
  • Education$30526%

General payments by program year

19
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,182 in reported general payments places this provider in the 65th percentile of 28 pediatric urology providers in Ohio.

See all pediatric urology providers in Ohio

Medicare billing

Part B allowed, 2024
$5,601
Medicare patients
46
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LithostatAcetohydroxamic Acid12$2,230

Paid to pharmacies, not to this prescriber.

Other pediatric urology in Columbus

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →